New gout pill shows promise in lowering uric acid levels
NCT ID NCT06139393
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tested a new tablet called HR091506 for adults with gout and high uric acid. It involved 765 participants and compared the new drug to an existing one, febuxostat. The main goal was to see if the new tablet could safely lower uric acid levels below a target threshold after 28 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT WITH HYPERURICEMIA IN ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.